BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Tazobactam

A penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria.

298+ PubMed studies analyzed · 15 RCTs · Evidence Score: 49.8

Research Domains

Tazobactam has been studied across 6 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🫁 Respiratory, 😴 Sleep, ✨ Skin & Hair. The primary research focus is 🫘 Kidney with 10% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tazobactam, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

bufo
2 shared targets
mylabris
2 shared targets
lycopus
2 shared targets
lithospermum
2 shared targets
anemarrhena
2 shared targets
cnidium
2 shared targets
scolopendra
2 shared targets
aster
2 shared targets
polygala
2 shared targets
belamcanda
2 shared targets
Loading evidence profile...

This evidence profile for Tazobactam is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.